Skip to content
Get alerts
GovInfoNow
Lower risk Medical device recall · FDA · Published January 8, 2024

BD BBL Sensi Disc Piperacillin/Tazobactam Recall: Risk of inaccurate antibiotic test

Becton Dickinson recalls BD BBL Sensi Disc Piperacillin/Tazobactam-100/10 ug for possible inaccurate antibiotic susceptibility testing, which could lead to delayed diagnosis or inappropriate treatment.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #Z-1037-2024Medical deviceBecton Dickinson ›
Take action

Contact the company

Recalling firmBecton Dickinson & Co.7 Loveton Cir · Sparks, MD 21152-9212
✎ GovInfoNow plain-language explainer

Becton Dickinson is recalling certain BD BBL Sensi Disc Piperacillin/Tazobactam-100/10 ug test strips used in antibiotic susceptibility testing. The recall is due to a risk of inaccurate test results, which could lead to delayed diagnosis or inappropriate antibiotic treatment. Read more at govinfonow.com/recall/56372-bd-bbl-sensi-disc-piperacillin-tazobactam-recall-risk-of-inaccurate.

Source Summary by GovInfoNow · govinfonow.com/recall/56372-bd-bbl-sensi-disc-piperacillin-tazobactam-recall-risk-of-inaccurate · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1037-2024

Cite this page

“BD BBL Sensi Disc Piperacillin/Tazobactam Recall: Risk of inaccurate antibiotic test.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/56372-bd-bbl-sensi-disc-piperacillin-tazobactam-recall-risk-of-inaccurate. Based on FDA recall #Z-1037-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1037-2024%22&limit=1).

Becton Dickinson & Co. recalled BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug on Jan. 8, 2024, according to the FDA. The device poses a risk of reproducibility and accuracy failures in antibiotic susceptibility testing for H. influenzae.

How to tell if you have it

  • Brand: Becton Dickinson
  • Product: BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug
  • Catalog No. 231691 UDI-DI 00382902316916 Lots 1301719 2026369 2056587 2119595 3003951 3062107 3118199 3275730
  • Catalog No. 231692 UDI-DI 30382902316924 Lots 3003951 3184117 3223408 3275730 1301719 2026369 2056587 2119595 2147716 2244463 3062107 3118199
  • Units: 2,363,168

The hazard

The FDA stated there is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

Context

GovInfoNow's records show Becton Dickinson & Co. has 43 other recalls on record since 2017-06-01. Other recent recalls of similar products include HardyDisk AST Cefiderocol 30μg FDC30: False Susceptibility Results Risk (2026-06-08) and Becton Dickinson Luer Tip Caps Recall: Failed Biocompatibility Testing (2025-10-14).

How to tell if you have this one

Check for catalog numbers 231691 or 231692. The product was sold with specific lot numbers listed in the recall notice.

  • Brand
    Becton Dickinson
  • Category
    Medical device
FDA recall event · 30 products

All 30 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Domestic distribution nationwide. International distribution worldwide.
Recall numberProduct, codes & lots
Z-1011-2024Sensi Disc Amoxicillin with Clavulanic Acid 20/10 ¿g, Catalog No. 231628 and 231629.¿ These discs are used for semi-quantitative in vitro susceptibility testing; Catalog No. 231628 UDI-DI 00382902316282 Lots 2090490 2146520 2210201 2276143 3062095; Catalog No. 231629¿¿ UDI-DI 30382902316290 Lots 3163306 3163307 3163310 3254307 3254309 3271840 3271853 2146520 2146526 2147225 2210201 2224295 2276143 2276144 3003894 3062095 3090649
Z-1012-2024BD BBL Sensi Disc Ampicillin - 10 ¿g, Catalog No. 230705 and 231264; 2 ¿g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility testing.; Catalog No. 230705 UDI-DI 00382902307051 Lots 1301474 1334111 2025840 2146318 2242344 2276051 2333100 3150355 3234179 ; Catalog No. 231264¿ UDI-DI 30382902312643 Lots 2333100 3030225 3058510 3150355 3234179 3282314 1301474 1334111 2003260 2025840 2146318 2242344 2276051; Catalog No. 231263 UDI-DI 30382902312636 Lots 3010977 3058508 3184064 3234190 1302042 2003517 2146414 2243865 2277199 2339360
Z-1013-2024BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 ¿g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing.; Catalog No. 231660¿ UDI-DI 30382902316603 Lots 3010074 3093387 3163062 3223403 3234193 2063349 2119619 2276123
Z-1014-2024BD BBL Sensi Disc Augmentin - 3¿g, Catalog Number 291270¿used for semi-quantitative in vitro susceptibility testing.; Catalog No. 291270¿ UDI-DI N/A Lots 3030893 3093584 3184136 Product not distributed in the US
Z-1015-2024BD BBL Sensi Disc Azithromycin -15 ¿g, Catalog Number 231682¿used for semi-quantitative in vitro susceptibility testing.; Catalog No. 231682¿ UDI-DI 30382902316825 Lots 3093408 3163065 2004501 2147712 2304517
Z-1016-2024BD BBL Sensi Disc Aztreonam - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640¿and 231641.; Catalog No. 231640¿ UDI-DI 00382902316404 Lots 1117192 1211613 1243750 1278287 3214945; Catalog No. ¿231641 UDI-DI 30382902316412 Lots 2304491 3093375 3184116 3214945 3261101 3282901 1117192 1211613 1278287 1305148 2004458 2028924 2090502 2244457
Z-1017-2024BD BBL Sensi Disc Cefaclor - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653¿; Catalog No. 231653¿ UDI-DI 30382902316535 Lots 1085898 1273095 1273096 2004485 2147706 2333108
Z-1018-2024BD BBL Sensi Disc Cefepime - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696¿; Catalog No. 231696¿ UDI-DI 30382902316962 Lots 2339439 3118297 3163524 3223410 3243084 3282873 2063393 2119624 2119625 2119626 2147720 2213567 2273732
Z-1019-2024BD BBL Sensi Disc Cefixime - 5 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664¿; Catalog No. 231664¿ UDI-DI 30382902316641 Lots 2004492 3010077 3223406 1305984 2091014
Z-1020-2024BD BBL Sensi Disc Cefotaxime - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607¿; 5 ug, Catalog No. 291308¿; Catalog No. 231606 UDI-DI 00382902316060 Lots 2004580 2025164 2090467 2146516 2180432 2301360 3003886; Catalog No. 231607 UDI-DI 30382902316078 Lots 2301360 3062270 3158078 3261093 2004580 2025164 2090467 2146516 2180432 3003886; Catalog No. 291308¿ UDI-DI N/A Lots 2301468 3003046 3093596 3116037 3248537 3248540
Z-1021-2024BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 and 231674¿; Catalog No. 231673 UDI-DI 00382902316732 Lots 3109152 3157106 3241174; Catalog No. 231674 UDI-DI 30382902316740 Lots 3157106 3241174 3109152
Z-1022-2024BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231¿; Catalog No. 232231¿ UDI-DI 30382902322314 Lots 3116030 3212690
Z-1023-2024BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632¿and 231633¿; Catalog No. 231632¿ UDI-DI 00382902316329 Lots 2004587 2028883 2119589 2146527 2242568 2301371 3118111 3181037; Catalog No. 231633¿ UDI-DI 30382902316337 Lots 2242568 2301371 3062286 3118111 3181037 3223389 3290192 2004587 2028232 2028883 2028894 2056528 2119589 2146527
Z-1024-2024BD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231634 and 231635¿; Catalog No. 231634 UDI-DI 00382902316343 Lots 1033870 1244758 2026381 2056573 2277488; Catalog No. 231635¿ UDI-DI 30382902316351 Lots 3062288 3158099 3254299 0344489 1033870 1088039 1116107 1148606 1180379 1211608 1244758 1335697 2026381 2028922 2056573 2180451 2277488 2277490
Z-1025-2024BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621¿; Catalog No. 231621¿ UDI-DI 30382902316214 Lots 2304487 3093372 3158087 3223379 1335657 2004439 2090487 2147701 2210631
Z-1026-2024BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733¿and 231274¿; Catalog No. 230733¿¿ UDI-DI 00382902307334 Lots 1020750 1116997 1180198 1211448 1277739 1301482 1334126 2025900 2063283 2210054 2277205 3003821 3129527 3263117 9336993 0080290 0178844 0258758; Catalog No. 231274¿ UDI-DI 30382902312742 Lots 2277205 3003821 3129527 3263117 0057245 0080290 1057453 1116997 1148461 1180198 1211448 1277739 1301482 1334126 2025900 2063283 2210054 9336993
Z-1027-2024BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657¿and 231658¿; Catalog No. 231657¿ UDI-DI 00382902316572 Lots 1060926 1279842 2028533 2091948 2301402 3214964 3248370; Catalog No. 231658¿ UDI-DI 30382902316580 Lots 1335458 2336475 3062295 3093427 3163048 3214964 3248370 0344330 1007112 1060926 1127037 1279842 1335457 2028533 2028547 2091948 2091980 2301402 2336474
Z-1028-2024BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678¿; Catalog No. 231678¿ UDI-DI 30382902316788 Lots 1305187 2119623 2339435 3129541
Z-1029-2024BD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232219¿; Catalog No. 232219¿ UDI-DI 30382902322192 Lots 3040749 3093444 3163515 3296612
Z-1030-2024BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175¿; Catalog No. 232174 UDI-DI 00382902321743 Lots 1301766 1341479 2119610 2147329 2242618 2276113 2333166 3152004 3181140; Catalog No. 232175¿ UDI-DI 30382902321751 Lots 1301766 2276113 2333166 2333175 3152004 3181140 1341479 2119610 2119612 2147329 2242618
Z-1031-2024BD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231644 and 231645¿; Catalog No. 231644 UDI-DI 00382902316442 Lots 1335006 2056580 2091918 2210318 2301385 3062101 3094134 3118125 3214950; Catalog No. 231645¿ UDI-DI 30382902316450 Lots 3062101 3094134 3118125 3214950 3261103 1335006 2056580 2081151 2091918 2091925 2147704 2210318 2210343 2277500 2301385
Z-1032-2024BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 and 231706¿; Catalog No. 231705 UDI-DI 00382902317050 Lots 1334510 2004644 2091272 2277179 3030830 3094117 3248344; Catalog No. 231706¿ UDI-DI 30382902317068 Lots 2277179 3030830 3094117 3184118 3248344 1334510 2004644 2091272 2213599
Z-1033-2024BD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231703 and 231704¿; Catalog No. 231703 UDI-DI 00382902317036 Lots 2147649 9065664; Catalog No. 231704¿ UDI-DI 30382902317044 Lots 2213585 3061281 3090652 3213825 2187975 2213583
Z-1034-2024BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231250 and 231251¿; Catalog No. 231250 UDI-DI 00382902312505 Lots 1085656 1277053 1301694 1334451 2025108 2119580 2146396 3181025; Catalog No. 231251¿ UDI-DI 30382902312513 Lots 1007140 2146396 3181025 3234149 1085656 1210753 1277053 1301694 1334451 2025108 2119580
Z-1035-2024BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758¿; Catalog No. 231758¿ UDI-DI 30382902317587 Lots 3003061 3243078 1305255 2119637 2153502 2301547
Z-1036-2024BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672¿; Catalog No. 231672¿ UDI-DI 30382902316726 Lots 1305177 2039254 2180484 2304476
Z-1037-2024BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231691 and 231692¿; Catalog No. 231691 UDI-DI 00382902316916 Lots 1301719 2026369 2056587 2119595 3003951 3062107 3118199 3275730; Catalog No. 231692¿ UDI-DI 30382902316924 Lots 3003951 3184117 3223408 3275730 1301719 2026369 2056587 2119595 2147716 2244463 3062107 3118199
Z-1038-2024BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and 231544¿; Catalog No. 231541 UDI-DI 00382902315414 Lots 1278110 1334479 2004554 2025125 2056466 2242510 3214931; Catalog No. 231544¿ UDI-DI 30382902315446 Lots 1116055 1211489 2339407 3030278 3158059 3214931 0343413 1032232 1088790 1148547 1278110 1334479 2004554 2025125 2056466 2090443 2242510
Z-1039-2024BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231536 and 231539¿; Catalog No. 231536 UDI-DI 00382902315360 Lots 1060689 1116935 1210905 1242939 1306103 1334461 2004540 2025116 2056456 2108378 2146453 2301307 3003869 3062089 3094151 3118079 3152968 3248444 0309595 0343394; Catalog No. 231539¿ UDI-DI 30382902315392 Lots 2339393 3003869 3062089 3094151 3118079 3152968 3214768 3248444 3282335 0309595 0343394 1060689 1116935 1148543 1210905 1242939 1306103 1334461 2004540 2025116 2056456 2108378 2146453 2277321 2301307
Z-1040-2024BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 and 231344¿; Catalog No. 230998 UDI-DI 00382902309987 Lots 1242880 1277918 1301570 2025088 2056233 2118569 2276681 3094187 3212760 3263267 9009914 9046895 0065366 0178210; Catalog No. 231344¿ UDI-DI 30382902313442 Lots 3010027 3062263 3094187 3158029 3212760 3263267 3275644 0065366 0085202 0230453 0274792 0335906 1095603 1148539 1180271 1242880 1277918 1301570 2025088 2056233 2089874 2118569 2276681 8355562 9009914 9046895 9130797 9239639 9263061
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the catalog number and lot numbers listed in the recall notice to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Domestic distribution nationwide. International distribution worldwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Jan 8, 202412. FDA classified it Class II: Feb 8, 202423. Published in FDA’s Enforcement Report: Feb 14, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Safeguard US Recalls Battle Bandages and IFAK Kits Due to Infection Risk
Safeguard US Operating LLCMiniMed Flex Insulin Pump Recall: Inaccurate Delivery Risk
Medtronic MiniMed, Inc.Medline Bariatric Rollator Recall: Detaching Wheels Risk
Medline Industries, LPCooperVision Pearle Vision 1 Day Contact Lenses: Incorrect Power Risk
CooperVision, Inc.Tandem t:slim App Recall: Pairing Issue With Abbott Sensors
Tandem Diabetes Care, Inc.

Latest medical device recalls

BMC Medical Co., Ltd. recalls BMC/REACTHEALTH Luna G3 APAP REF LG 3600
BMC Medical Co., Ltd. · July 15, 2026Medtronic MiniMed, Inc. recalls MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
Medtr: MiniMed · July 13, 2026INTEGRATED MEDCRAFT LLC recalls Kingfisher Compact Individual First Aid Kit. REF Number: 76656. Containing the affected One-piece Guedel airway
Medcraft · July 7, 2026Pride Mobility Products Corp. recalls Brand Name: Quantum Rehab Product Name: R-TRAK Model/Catalog Number: R-TRAK Software Version: 2.0.11, new version:
Quantum Rehab · June 25, 2026ResMed Ltd. recalls Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory
ResMed · June 25, 2026Therabody, Inc recalls Charger for the Therabody Theragun, G4 PRO massage device, and products which include the 4th Generation Theragun PRO
Therabody · June 23, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1037-2024 (January 8, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1037-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA